SCHEMBL10429308

SCHEMBL10429308

COc1ccc(-n2ncc3c(=O)[nH]nnc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.50
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
XDH P47989 1/20 0.50
HTT P42858 5/20 0.49
LMNA P02545 5/20 0.49
TSHR P16473 3/20 0.49
POLB P06746 2/20 0.49
HPGD P15428 4/20 0.48
RAB9A P51151 7/20 0.47
NPC1 O15118 6/20 0.47
ALDH1A1 P00352 6/20 0.47
MAPT P10636 5/20 0.47
S1PR4 O95977 1/20 0.47
S1PR1 P21453 1/20 0.47
PAX8 Q06710 1/20 0.47
NPSR1 Q6W5P4 2/20 0.46
XBP1 P17861 1/20 0.46
KDM4E B2RXH2 5/20 0.45
HSD17B10 Q99714 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10429315 0.81 ALDH1A1 (0.50) SMN1; SMN2KMT2AMEN1HTTLMNA
SCHEMBL10429351 0.81 LMNA (0.44) SMN1; SMN2HTTLMNATSHRALDH1A1
SCHEMBL10429319 0.80 POLB (0.50) SMN1; SMN2LMNAPOLBRAB9AALDH1A1
SCHEMBL17869621 0.78 XDH (0.60) SMN1; SMN2KMT2AMEN1XDHHTT
SCHEMBL10429355 0.73 DAPK3 (0.52) SMN1; SMN2KMT2ALMNATSHRHPGD
SCHEMBL23047007 0.71 SMN1; SMN2 (0.51) SMN1; SMN2KMT2AMEN1XDHHTT
SCHEMBL19342074 0.69 SMN1; SMN2 (0.46) SMN1; SMN2KMT2AMEN1XDHHTT
SCHEMBL10429338 0.69 KMT2A (0.46) SMN1; SMN2KMT2AMEN1XDHHTT
SCHEMBL8306261 0.69 PDE9A (0.64) SMN1; SMN2KMT2AMEN1HTTLMNA
SCHEMBL9918804 0.68 CMA1 (0.43) KMT2AMEN1LMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0274654-A2 1,2,3-Triazin-4(3H)-one derivatives, process for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE AG (CH) 1988-07-20 EP claimed
US-4920119-A XANTHINE OXIDASE INHIBITORS; CONTROL OR PREVENTION OF GOUT OR ISCHEMIA HOFFMANN-LA ROCHE INC. (US) 1990-04-24 US disclosed
EP-0274654-A2 1,2,3-Triazin-4(3H)-one derivatives, process for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE AG (CH) 1988-07-20 EP disclosed